Share Name Share Symbol Market Type Share ISIN Share Description
Eco Animal Health Group Plc LSE:EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 345.00p 330.00p 360.00p 345.00p 345.00p 345.00p 425,485 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 74.6 15.2 17.6 19.6 233

Eco Animal Health Share Discussion Threads

Showing 801 to 825 of 1075 messages
Chat Pages: 43  42  41  40  39  38  37  36  35  34  33  32  Older
DateSubjectAuthorDiscuss
06/8/2017
22:58
A bit of fun so I had a quick look back at the old thread and found this post of mine.....tho at the time never thought it would take that long! tanners 25 Jul '07 - 23:25 - 579 of 585    0   0   Edit I've been a long term follower of this stock, but I've gotta say, these latest results are poor. For the last 3 years or so, income has been generated by various selling of bits of the business, and now it's stripped down to the core, still it can't generate positive cash flow. I sold ages ago at around #3.60 as it I thought it had too far ahead of itself, and I've followed it since looking for a re entry, but I've gotta say I'm disappointed, and think it's still over valued at current prices. Great business model with barriers to entry of it's market, but the earnings just don't justify this price imo, so it's wait and see. Well worth keeping on the watch list, but I won't be tempted until I see better value than currently exists........I've called this down for some time, and sadly I still think it's a one way ticket.
tanners
06/8/2017
22:56
Agreed - good to see some more interest and new investors. And whilst the rise over the last year may put some off, it's worth remembering that they have taken years to develop these products, get the Regulatory approvals and build a customer base. I was invested in their previous incarnation, Lawrence (LAC) nearly 15 years ago, and sold out as I felt the progress was too slow then re invested again last year, having had them on my watch list for over 10 years! Personally, I'm never bothered about buying at a new high, as long as I think there is still value to be had....and that's been the case in my most of my best performing shares.
tanners
03/8/2017
11:48
Nice to see some new contributors here on what is normally a very quiet board. EAH still seems, surprisingly to me, to be 'off the radar' for so many and yet it has a lot going for it as a safe, reliable, growth share.
aimingupward2
02/8/2017
14:14
And you Jim, great minds thinking alike! I've had a great run recently with BUR, IQE and TAP all doing the business, but I have high hopes here and also for HCM. Big growth, growing margins, untapped market and profitable. A lot to like here.
mad foetus
02/8/2017
13:25
Mad, Good to see you invested here.
jimbowen30
02/8/2017
11:55
I've bought a few today, may well be just an initial tranche if things pan out.
mad foetus
28/7/2017
12:19
Just added another couple of 9k tranches.
monnow
27/7/2017
12:10
Some good points. I bought an initial stake yesterday and see this very much a long term holding.
jimbowen30
25/7/2017
12:19
Also giving confidence is, as I have mentioned before, Peel Hunt's view at the time of the results at the end of June, that EAH has a period of "stellar growth" ahead of it. That's not the sort of phrase they would use lightly, I wouldn't have thought. Of how many other companies have they said that, I wonder. Very (or very, very) few I suspect.
aimingupward2
24/7/2017
23:49
jimbowen30 - I for one wouldn't still be invested if I didn't think there wasn't further significant growth. One of the key metrics I like about ECO is that a rise in turnover is reflected by a disproportionately bigger rise in net profits, and therefore EPS.....which is usually a strong indicator of a unique product/brand. To give an example, over the last 3 years turnover has increased just under 100% (£32M to £61M), whereas EPS have increased by 270% (4.35p to 16.17p). China, Japan & the Indian sub continent were the main reason for the growth last year, but from the interims the current year has started at record levels, and the number of new Regulatory Approvals is also increasing: 2014 - 3, 2015 - 2, 2016 - 5, 2017 - 3 to date. Of the 5 granted in the calendar year 2016, 2 were late in the year therefore the will have a full impact in this financial current year. My mindset is that significant growth is still achievable for some time to come, which therefore justifies a current P/E ratio which might look pricey at first glance.
tanners
24/7/2017
23:08
I have been following the company closely for a while now but haven't bought in yet. Do you all still see a lot of further upside, given the valuation?
jimbowen30
24/7/2017
22:58
Thanks aimingupward. Yes I am very much onboard,Although I am a seasoned investor, my attention was originally drawn to eco, through my small upland sheep farm, and the associated parallels that draws.
monnow
24/7/2017
20:42
Welcome aboard, monnow (assuming you are 'on board', that is). How did you find us I wonder?
aimingupward2
24/7/2017
19:19
5 actually Topvest. Cant believe a company growing eps and turnover so fast is so under the radar !!
monnow
24/7/2017
18:18
Really good news that there are only 4 of us on the BB on a day like today. Bodes well when others decide they like the story as well. Rare stock this one. A storyboard stock which has delivered but no interest. Very different to the likes of say Fevertree that has also delivered, but everyone is in it.
topvest
24/7/2017
08:56
Indeed this certainly opens up lots more business opportunity and should reflect in a further healthy increase in the bottom-line.
audigger
24/7/2017
08:00
This is an important approval which the company, and it's brokers, have been looking forward to receiving for some while now. It can be expected to give a significant lift to future U.S sales and put EAH on track to doubling it's share of that major market.
aimingupward2
24/7/2017
07:09
Yes, agreed. Always good to get a regulatory approval, but this one is the second in the U.S.A. which has to be a valuable one.
topvest
24/7/2017
07:04
Boom excellent news
hydrus
03/7/2017
22:47
No, they're not "bound to say that". They could have said nothing about becoming "a major force" if there was no ambition to achieve that or no real likelihood of it happening.
aimingupward2
02/7/2017
21:40
They are bound to say that in my view. If they said the company was up for sale then that would be a sign of weakness.
topvest
02/7/2017
14:10
"I sense they may now be thinking that they themselves can become a big player" No surprise there, Au. The ambition to grow has been clear for a while now. If you look back at earlier regulatory approvals, it has been said on several occasions that each "underlines ECO's continued commitment to being a major force in the international market for veterinary pharmaceutical products." So plenty of headroom left. Really plenty!
aimingupward2
30/6/2017
23:18
I agree, Au. It's just plain daft, too, to quote an eps for the year to March '18 of barely a penny above the figure just announced in today's results when the company says it has started the year strongly and recent marketing approvals will be at the early stages of generating income. Moreover, EAH itself says that EBDITA should be taken as the prime measure of performance, not eps, since the company is obliged to write off development and registration costs each year, thus reducing eps, whereas each new marketing approval achieved improves the scope for future earnings and enhances the company's value. A bit too difficult for Fools to cope with, perhaps.
aimingupward2
30/6/2017
22:09
The Fool article illustrates how applying fundamentals to a share like this is flawed (in my opinion). To base on investment decision on PE ratio alone is somewhat missing the point with respect to the business model. The investment and time to get their key product to market, their patents, low residue profile, complexity of manufacture, resistance profile, efficacy and ease of administration mean that they effectively have no serious competition in the space they are operating. Put all of this together with the ability to raise prices and increase margins and you have a highly cash generative business. If, as stated, they use the cash to fund organic growth, in addition to the strong growth in business for the older chemistries, then PE is meaningless! Waiting for a pull-back may not be wise.....though would be a great opportunity to add if it happens.
audigger
30/6/2017
17:33
Decent results here today! http://www.fool.co.uk/investing/2017/06/30/is-this-small-cap-growth-stock-a-bargain-after-todays-results/
eddyeagle1979
Chat Pages: 43  42  41  40  39  38  37  36  35  34  33  32  Older
Your Recent History
LSE
EAH
Eco Animal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191019 20:27:02